• Lead site qualification, feasibility, and readiness activities for assigned clinical trial sites. • Own site startup and activation activities, including collection and review of essential regulatory and startup documentation. • Ensure investigators, study coordinators, and site personnel are prepared to enroll patients efficiently and compliantly. • Partner with the Clinical Trials Manager and study leadership on site contracting and budgeting activities and ensure timely site activation. • Track startup milestones and proactively identify and resolve activation barriers. • Serve as the primary operational contact for assigned clinical trial sites. • Build and maintain strong relationships with investigators, coordinators, and site personnel. • Drive patient screening and enrollment activities to achieve study recruitment goals. • Own site performance across assigned sites and implement actions to improve enrollment, protocol adherence, and study execution. • Partner with sites to address operational challenges and maintain study momentum. • Conduct site initiation visits and provide study-specific training to investigators and site personnel. • Deliver ongoing site education throughout study execution. • Ensure study activities are conducted in accordance with the protocol, GCP, FDA regulations, and company procedures. • Participate in investigator meetings, study team meetings, and site training activities. • Conduct monitoring activities as required to ensure study quality, compliance, and protocol adherence. • Review site documentation and study records for completeness and accuracy. • Identify protocol deviations, compliance concerns, and operational risks and escalate appropriately. • Ensure site documentation is complete, accurate, maintained in accordance with study requirements, and inspection-ready at all times. • Partner closely with the Clinical Trials Manager, Sr. Clinical Program Manager, Clinical Affairs, Regulatory, Quality, and Data Management teams. • Communicate site feedback, enrollment trends, operational challenges, and emerging risks to study leadership. • Contribute to continuous improvement of site activation, enrollment, and study execution processes.

• Collect, analyze, and maintain institutional data related to enrollment, student success, faculty, academic programs, and operations • Prepare and submit external reports for reporting and compliance submissions • Develop internal reports and dashboards that provide actionable insights for internal stakeholders • Maintain data integrity and consistency across institutional systems and reports • Partner with academic and administrative leaders to collect and interpret data that informs strategic priorities, enrollment planning, resource allocation, and program development • Support institutional and departmental planning processes by developing metrics, benchmarks, and trend analyses • Provide data and analysis for board and executive reports, accreditation self-studies, and strategic planning updates • Collaborate with internal stakeholders to collect and interpret assessment data for programs and institutional outcomes • Support program review and accreditation processes with data, documentation, and analysis • Identify patterns and opportunities for student learning, retention, and success improvement • Design, administer, and analyze institutional surveys for internal and external stakeholders • Summarize results and present findings in accessible, visual, and narrative formats • Develop systems and practices for data stewardship, reporting schedules, and consistent data definitions • Promote data literacy and transparency across the college • Communicate complex information clearly to both technical and non-technical audiences • Perform other duties as assigned • Represent MCAD’s vision, mission, and values

Role Description The External Innovation Partner, Oncology Research - Targeted Protein Degradation & Induced Proximity is a scientific leadership role that serves as an External Catalyst, connecting Astellas Oncology Research with leading external innovation ecosystems in targeted protein degradation, induced proximity, and degrader-conjugate science. This role proactively identifies, evaluates, and shapes external opportunities across: - PROTACs - Molecular glues - Monovalent/direct degraders - Degrader platforms - E3/UPS biology including CRBN, VHL, and novel E3 ligases - Target engagement - Proteomics/chemoproteomics - Structural and computational degrader design - Degrader Antibody Conjugates (DACs) - Next-generation induced-proximity technologies such as RIPTAC and TCIP - Other oncology-relevant targeted-delivery or induced-proximity modalities The role translates external scientific signals into research hypotheses, differentiation logic, critical-assumption questions, and scientific assessments that guide research strategy and support BD-led partnership discussions in close collaboration with internal research leaders. Responsibilities and Accountabilities - External Ecosystem Engagement & Catalytic Scouting: - Build trusted access to academic investigators, KOLs/KEEs, biotech founders, incubators, investors, CROs, tech-transfer offices, venture creation groups, and scientific consortia focused on TPD, induced proximity, oncology chemical biology, proteomics, and degrader-conjugate science. - Prioritize engagement with leading innovation ecosystems and global centers of excellence in degrader science, induced proximity, oncology research, chemical proteomics, and DAC/degrader-conjugate technologies. - Represent Astellas Oncology Research at major scientific conferences, innovation forums, targeted partnering events, and academic meetings to uncover early-stage opportunities before they become broadly visible. - Actively track scientific and company activity across PROTACs, molecular glues, monovalent/direct degraders, novel E3 ligase recruiters, CRBN/VHL biology, target engagement, proteomics/chemoproteomics, next-generation induced-proximity technologies such as RIPTAC and TCIP, and DACs. - Maintain dynamic hub heatmaps, KEE maps, company/platform landscapes, and opportunity pipelines that enable rapid triage and high-quality internal decision-making. - Scientific Opportunity Identification & Strategic Insight: - Identify high-impact external science, platform technologies, targets, mechanisms, and translational capabilities with potential relevance to Astellas oncology research priorities and future portfolio options. - Assess TPD and induced-proximity opportunities based on target biology, degradability, modality fit, E3/UPS strategy, mechanism of action, target engagement, proteomic selectivity, cellular pharmacology, DMPK/PK-PD, differentiation, competitive positioning, and development risk. - Evaluate platform-partnership opportunities for scientific maturity, scalability, target-ligase knowledge, assay/model access, reproducibility, IP/FTO considerations, and potential to unlock difficult-to-drug or previously inaccessible oncology targets. - For DAC or degrader-conjugate opportunities, assess tumor antigen selection, internalization/trafficking biology, targeting vehicle properties, linker-payload strategy, degrader payload mechanism, degradation readouts, tumor selectivity, safety liabilities, and fit with Astellas capabilities. - Translate early-stage innovation signals into strategic insights that support research prioritization, portfolio planning, and exploratory evaluation of external opportunities. - Cross-Functional Collaboration & Knowledge Integration: - Collaborate closely with Research Strategy Leads, Modality Intelligence Leads, Innovation Intelligence Analysts, and other subject-matter experts to ensure insights are shared and acted upon. - Support BD-led opportunity evaluation in collaboration with Business Development and relevant embedded partners by providing scientific framing, diligence questions, data-package interpretation, and strategic context. - Contribute to the development of intelligence infrastructure and best practices for horizon scanning, opportunity mapping, and external engagement across CI & RPM. Qualifications - Advanced degree (PhD, MD, MBA, or equivalent) in Oncology, Life Sciences, or a related field. - Minimum 8 years of experience in pharmaceutical R&D, external innovation, academic collaboration, or scientific partnering. - Strong understanding of oncology drug discovery, translational science, and modality platforms (e.g., next gen ADCs, engineered biologics, engineered small molecules). - Proven ability to engage with scientific leaders and navigate early-stage biotech and academic ecosystems. - Excellent communication skills with the ability to synthesize complex scientific information into strategic insights. - Prior experience in academic liaison, external innovation, or strategic scouting in pharma/biotech or venture ecosystems. - Familiarity with CI platforms, digital literature monitoring tools, and academic/biotech databases. - A strong network in academia or biotech focused on oncology. - Experience in competitive intelligence, scientific scouting, or innovation strategy within oncology. - Familiarity with academic-industry collaboration models and consortia-based innovation. - High digital literacy and comfort with landscape analytics, scientific intelligence platforms, and conference tracking tools. Benefits - Medical, Dental and Vision Insurance - Generous Paid Time Off options, including Vacation and Sick time, plus national holidays including year-end shut down - 401(k) match and annual company contribution - Company paid life insurance - Annual Corporate Bonus and Quarterly Sales Incentive for eligible positions - Long Term Incentive Plan for eligible positions - Company fleet vehicle for eligible positions - Referral bonus program

• Organization, coordination and monitoring of clinical studies in accordance with ICH and GCP guidelines and internal SOPs • Recruitment, selection and training of investigators and study sites • Conducting site initiation visits, routine monitoring (on-site / remote) and close-out visits at study sites across Germany, including site communication and written documentation • Identifying on-site issues and escalating them to the study sponsor • Preparation and submission of documents to ethics committees and federal authorities, and support with correspondence • Tracking appointments and deadlines • Maintaining study data in databases (Access, Excel) • Support with submission activities / maintenance of the Trial Master File (TMF)